"Carriers of the gene mutation that causes this form of hyperplasia have roughly a 12.5% chance of having a daughter with the condition. The hormone treatment must be started as soon as possible, before the gender of the child is determined, for it to have an effect on genital development."
There is no medical group that appears ready to recommend research on the drug stop (medical types would never discourage this, of course), it seems like a slippery slope that will lead to the drug, or a variant, being used on boys to cure their homosexuality before they leave the womb.
0 comments:
Post a Comment